HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Veradigm (MDRX)…

SAN FRANCISCO, March 24, 2023 (GLOBE NEWSWIRE) — Hagens Berman calls on Veradigm Inc. (NASDAQ: MDRX) Investors who have suffered significant losses Submit your losses now. Veradigm Inc. (MDRX) Investigation: The investigation focuses on the accuracy of Veradigm’s revenue recognition practices. On February 28, 2023, Veradigm announced that it would not be filing its fourth […]